Candidemia in Left Ventricular Assist Device Recipients: Incidence, Risk Factors, and Outcomes
C-BSI occurs early in LVAD recipients and is associated with a high mortality rate. Identified risk factors identified may guide antifungal prophylaxis or early empiric antifungal treatment in this susceptible patient population.
Authors
- Rebecca Anderson (ORCID: https://orcid.org/0000-0003-3862-871X)
- Stephanie M. Pouch (ORCID: https://orcid.org/0000-0002-5628-2444)
- Emily M. Eichenberger (ORCID: https://orcid.org/0000-0002-2469-0638)
- Theresa Hayes (ORCID: https://orcid.org/0000-0002-4266-9066)
- Joshua L. Chan (ORCID: https://orcid.org/0000-0001-7220-561X)
- Susie Sennhauser (ORCID: https://orcid.org/0000-0001-5817-786X)
- Lindsay M. Busch (ORCID: https://orcid.org/0000-0002-5332-5883)
Institutions
- Emory University (US)
Publication Details
- Journal
- Open Forum Infectious Diseases
- Published
- 2025-04-25
- DOI
- https://doi.org/10.1093/ofid/ofaf251
- Citations
- 1
- Primary Topic
- Antifungal resistance and susceptibility
- Type
- article
- Field-Weighted Citation Impact
- 1.40
Funders
- National Institutes of Health
- National Center for Advancing Translational Sciences